FDA’s Role in the New Era of Medtech Collaboration

As we've recently noted, the shift toward a value-based care system has inspired a new era of collaboration in the medical device industry, including the emergence of risk-sharing contracts. While these agreements primarily involve manufacturers, providers, and payers, is it too much of a stretch to think FDA might, at some point, play a role in that trend?